132 related articles for article (PubMed ID: 10973857)
1. Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Bergquist J; Andersen O; Westman A
Clin Chem; 2000 Sep; 46(9):1293-300. PubMed ID: 10973857
[TBL] [Abstract][Full Text] [Related]
2. Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation.
Terazaki H; Ando Y; Nakamura M; Obayashi K; Misumi S; Shoji S; Yamashita S; Nakagawa K; Ishizaki T; Suhr O; Uemoto S; Inomata Y; Tanaka K
Transplantation; 2001 Jul; 72(2):296-9. PubMed ID: 11477356
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy.
Tachibana N; Tokuda T; Yoshida K; Taketomi T; Nakazato M; Li YF; Masuda Y; Ikeda S
Amyloid; 1999 Dec; 6(4):282-8. PubMed ID: 10611950
[TBL] [Abstract][Full Text] [Related]
4. [Application to transthyretin analysis].
Ueda M; Ando Y
Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of wild-type and mutated transthyretins.
Tasaki M; Ueda M; Obayashi K; Motokawa H; Kinoshita Y; Suenaga G; Yanagisawa A; Toyoshima R; Misumi Y; Masuda T; Yamashita T; Ando Y
Ann Clin Biochem; 2016 Jul; 53(Pt 4):508-10. PubMed ID: 26342004
[TBL] [Abstract][Full Text] [Related]
6. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
Lim A; Prokaeva T; McComb ME; O'Connor PB; Théberge R; Connors LH; Skinner M; Costello CE
Anal Chem; 2002 Feb; 74(4):741-51. PubMed ID: 11866053
[TBL] [Abstract][Full Text] [Related]
7. A novel compound heterozygote (FAP ATTR Arg104His/ATTR Val30Met) with high serum transthyretin (TTR) and retinol binding protein (RBP) levels.
Terazaki H; Ando Y; Misumi S; Nakamura M; Ando E; Matsunaga N; Shoji S; Okuyama M; Ideta H; Nakagawa K; Ishizaki T; Ando M; Saraiva MJ
Biochem Biophys Res Commun; 1999 Oct; 264(2):365-70. PubMed ID: 10529370
[TBL] [Abstract][Full Text] [Related]
8. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
Liu J; Lan J; Zhao P; Zheng F; Song J; Zhang P; Sun X
Int J Clin Exp Pathol; 2014; 7(11):7795-800. PubMed ID: 25550818
[TBL] [Abstract][Full Text] [Related]
9. Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid.
Ando Y; Suhr O; Yamashita T; Ohlsson PI; Holmgren G; Obayashi K; Terazaki H; Mambule C; Uchino M; Ando M
Neurosci Lett; 1997 Dec; 238(3):123-6. PubMed ID: 9464635
[TBL] [Abstract][Full Text] [Related]
10. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met).
Ando Y; Ando E; Ohlsson PI; Olofsson A; Sandgren O; Suhr O; Terazaki H; Obayashi K; Lundgren E; Ando M; Negi A
Amyloid; 1999 Jun; 6(2):119-23. PubMed ID: 10439118
[TBL] [Abstract][Full Text] [Related]
11. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Teixeira AC; Saraiva MJ
J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326
[TBL] [Abstract][Full Text] [Related]
12. Variant transthyretin in cerebrospinal fluid in familial amyloidotic polyneuropathy.
Nakazato M; Kangawa K; Kurihara T; Matsukura S; Matsuo H
J Neurol Sci; 1987 Jun; 79(1-2):111-6. PubMed ID: 3039062
[TBL] [Abstract][Full Text] [Related]
13. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
Yamashita T; Ando Y; Bernt Suhr O; Nakamura M; Sakashita N; Ohlsson PI; Terazaki H; Obayashi K; Uchino M; Ando M
J Neurol Sci; 2000 Feb; 173(2):154-9. PubMed ID: 10675660
[TBL] [Abstract][Full Text] [Related]
14. A new nonamyloid transthyretin variant, G101S, detected by electrospray ionization/mass spectrometry. Mutations in brief no. 201. Online.
Kishikawa M; Nakanishi T; Miyazaki A; Hatanaka M; Shimizu A; Tamoto S; Ohsawa N; Hayashi H; Kanai M
Hum Mutat; 1998; 12(5):363. PubMed ID: 10671063
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis.
Mitsuhashi S; Yazaki M; Tokuda T; Sekijima Y; Washimi Y; Shimizu Y; Ando Y; Benson MD; Ikeda S
Amyloid; 2005 Dec; 12(4):216-25. PubMed ID: 16399646
[TBL] [Abstract][Full Text] [Related]
16. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
Ando Y
Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
[TBL] [Abstract][Full Text] [Related]
17. A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.
da Costa G; Guerreiro A; Correia CF; Gomes RJ; Freire A; Monteiro E; Barroso E; Coelho AV; Outeiro TF; Freire AP; Cordeiro C
Proteomics Clin Appl; 2010 Jul; 4(6-7):674-8. PubMed ID: 21179887
[TBL] [Abstract][Full Text] [Related]
18. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Théberge R; Connors L; Skinner M; Skare J; Costello CE
Anal Chem; 1999 Jan; 71(2):452-9. PubMed ID: 9949732
[TBL] [Abstract][Full Text] [Related]
19. Two transthyretin mutations (glu42gly, his90asn) in an Italian family with amyloidosis.
Skare J; Jones LA; Myles N; Kane K; Milunsky A; Cohen A; Skinner M
Clin Genet; 1994 Jun; 45(6):281-4. PubMed ID: 7923855
[TBL] [Abstract][Full Text] [Related]
20. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.
Nomura T; Ueda M; Tasaki M; Misumi Y; Masuda T; Inoue Y; Tsuda Y; Okada M; Okazaki T; Kanenawa K; Isoguchi A; Nakamura M; Obayashi K; Shinriki S; Matsui H; Yamashita T; Ando Y
Orphanet J Rare Dis; 2019 May; 14(1):116. PubMed ID: 31133063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
